Solace Health raises $130 million in Series C funding round at over $1 billion valuation, led by IVP (Institutional Venture Partners) with participation from existing investors Menlo Ventures, SignalFire, Torch Capital, Inspired Capital, and RiverPark Ventures.
As of February 2026, Solace Health has raised a total of over $210 million in funding to date, according to the latest funding data compiled by Healthitmedia.com (Health IT Media). Solace Health previously closed a $60 million Series B funding in April 2025, led by Menlo Ventures. The startup secured $14 million in Series A funding in April 2024, led by Inspired Capital.
Based in California, Solace Health offers a patient-centric care navigation platform that connects patients with expert advocates (via phone, text, or email) covered by insurance. Solace Health presently offers patient advocacy services nationwide across all 50 states in the U.S.
With fresh funding, Solace plans to significantly expand its national network of more than 2,000 experienced advocates serving Medicare and Medicare Advantage members, while accelerating investment in its platform and clinical research. The company will also deepen partnerships with payers and providers to embed advocacy earlier in the care journey where outcomes are most at risk.
Founded in 2022, Solace Health now serves more than 20,000 patients monthly through its HIPAA-compliant platform, connecting them with expert advocates via text, phone, and video.
Digital health companies have secured more than $170 billion in venture capital funding to date, according to the latest funding data compiled by Digital Health Funding. More recently, Pasito, a provider of AI-powered personalized employee health benefits and retirement benefits solutions, raised $21 million in Series A funding.